ArticleThe Journal of biological chemistry2016

Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation.

Elodie Weider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.